查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
溶瘤病毒治疗市场 - 2023-2031 年成长、未来前景、竞争分析
市场调查报告书
商品编码
1422201

溶瘤病毒治疗市场 - 2023-2031 年成长、未来前景、竞争分析

Oncolytic Virus Therapy Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日期: | 出版商: Acute Market Reports | 英文 114 Pages | 商品交期: 最快1-2个工作天内

价格

由于技术创新、应用范围扩大和强大的研究前景，预计 2024 年至 2032 年预测期内，溶瘤病毒治疗市场将以 27.5% 的复合年增长率成长。重组 Oncolyte 病毒、Oncolyte 野生型病毒以及实体瘤和黑色素瘤的标靶应用正在定义治疗前景。儘管面临挑战，医疗保健专业人士、研究人员和行业领导者的集体努力正在使市场走上乐观的轨道。区域动态凸显了北美和亚太地区在塑造市场未来的重要性。竞争趋势凸显关键参与者的策略策略，增强市场竞争力。在预测期内，溶瘤病毒治疗市场预计将见证变革性的市场发展，并重申其在肿瘤学领域的重要性。

溶瘤病毒治疗市场的关键市场驱动因素

重组溶瘤病毒研究进展

使用基因工程溶瘤病毒是癌症治疗中令人兴奋的前沿领域。这些病毒经过专门设计，可以选择性地靶向癌细胞，同时保护健康组织，从而最大限度地减少与传统治疗相关的副作用。具有增强肿瘤特异性、增强复製能力和增强治疗有效负载的新兴本土病毒的市场发展正在推动该市场向前发展。临床试验的证据强调了这些病毒在多种癌症类型中的有效性和安全性，激发了研究人员和临床医生的乐观情绪。

癌细胞野生型病毒是治疗创新的驱动力

主要应用于实体肿瘤和黑色素瘤

溶瘤病毒治疗市场的限制因素

实现统一治疗反应的挑战

儘管取得了有希望的进展，但在不同患者群体中实现统一的治疗反应仍然存在挑战。个别免疫反应的变化、肿瘤异质性和癌症的演变性质为溶瘤病毒治疗的标准化治疗结果带来了障碍。有证据显示某些患者的反应有限，凸显了个别化治疗策略的必要性。克服这些挑战需要更深入地了解病毒、肿瘤和免疫系统之间的复杂相互作用。

市场区隔分析

依病毒类型细分基因工程溶瘤病毒与溶瘤野生型病毒的比较（500字）

2023年，基因改造病毒和野生型病毒在溶瘤病毒治疗市场中都占据了重要的收入份额。基因改造病毒占据了压倒性的市场份额，反映出癌症治疗客製化的趋势。预计 2024 年至 2032 年，由于持续的研究努力和经过验证的功效，基因工程病毒将继续占据主导地位。然而，我们预期溶剂化的野生型病毒会获得关注，特别是在病毒的固有特性与治疗目标相符的应用中。

依用途细分：实体瘤与黑色素瘤（500 字）

2023年，涵盖多种癌症类型的实体癌症将成为溶瘤病毒治疗的主要用途。实体瘤应用在预测期内具有最高的收入和复合年增长率，凸显了该疗法的广泛用途。黑色素瘤的特征是治疗难度大，但已显示出显着的增长，并且在复合年增长率方面处于领先地位。黑色素瘤的独特特征，包括其免疫原性，使其成为溶瘤病毒治疗的理想候选者。

依最终用途细分医院、专科诊所、癌症研究机构（500 个字元）

医院、专科诊所和癌症研究机构是塑造溶瘤病毒治疗市场的主要最终用户。2023 年，医院的收入和复合年增长率均处于领先地位，反映出它们在提供全面癌症护理方面的核心作用。专科诊所由于采用密集的癌症治疗方法而显示出较高的复合年增长率。处于技术创新前沿的癌症研究机构为治疗的进步做出了重大贡献。这项预测凸显了医院的持续主导地位，专科诊所的显着成长。

北美仍处于世界领先地位

北美凭藉强大的医疗基础设施和大量的研究投入，2023年的销售额比率和复合年增长率均排名第一。该地区对创新和合作研究措施的承诺为市场扩张创造了有利的环境。在欧洲，虽然复合年增长率较高，但销售额比例略落后于北美。亚太地区的复合年增长率最高，代表尚未开发的潜力，医疗保健市场快速成长，人们对先进治疗的认识不断增强。中东和非洲地区市场贡献较小，影响区域动态的因素较多。

策略联盟扩大市场份额

包括製药巨头和创新生物技术公司在内的领先公司正在战略联盟和技术进步所塑造的市场格局中航行。到 2023 年，这些参与者将公布可观的收入，预计 2024 年至 2032 年将进一步成长。Amgen、Genelux Corporation、Oncolytics Biotech、Sorrento Therapeutics、Transgene SA、Daiichi Sankyo Company、Shanghai Sunway Biotech Co Ltd、Takara Bio Inc.、PsiOxus Therapeutics、SillaJen Inc.、ViroCure等领先公司采取了多元化的策略。市场地位。与研究机构合作、扩大产品组合以及投资临床试验是推动这些公司前进的关键策略举措。

目录

第一章 前言

  • 报告内容
    • 报告目的
    • 目标群众
    • 主要提供产品
  • 市场细分
  • 调查方法
    • 第一阶段—二次调查
    • 第二阶段-初步调查
    • 第三阶段-专家评审
    • 先决条件
    • 采取的方法

第二章执行摘要

第三章溶瘤病毒治疗市场：竞争分析

  • 主要供应商的市场地位
  • 供应商采取的策略
  • 主要产业战略
  • 等级分析：2023 年 vs 2032 年

第四章溶瘤病毒治疗市场：宏观分析与市场动态

  • 介绍
  • 2022-2032年全球溶瘤病毒治疗市场价值
  • 市场动态
    • 市场驱动力
    • 市场制约因素
    • 主要问题
    • 主要机会
  • 促进因素和抑制因素的影响分析
  • 跷跷板分析
  • 波特的五力模型
    • 供应商实力
    • 购买力
    • 替代品的威胁
    • 新进入者的威胁
    • 竞争对手之间的竞争
  • PESTEL 分析
    • 政局
    • 金融情况
    • 技术景观
    • 法律状况
    • 社会局势

第五章溶瘤病毒治疗市场：依病毒类型 2022-2032

  • 市场概况
  • 成长/利润分析：2023 年与 2032 年
  • 2022-2032年数量和价格分析
  • 市场细分
    • 基因工程溶瘤病毒
      • 单纯疱疹病毒
      • 腺病毒
      • 痘苗病毒
    • 溶瘤野生型病毒
      • 呼肠孤病毒
      • 新城疫病毒
      • 水泡性口炎病毒

第六章溶瘤病毒治疗市场：依应用分类 2022-2032

  • 市场概况
  • 成长/利润分析：2023 年与 2032 年
  • 2022-2032年数量和价格分析
  • 市场细分
    • 实体肿瘤
      • 乳腺癌
      • 前列腺癌
      • 肺癌
      • 胶质母细胞瘤
    • 黑色素瘤
      • 血液系统恶性肿瘤
      • 淋巴瘤
      • 白血病
      • 骨髓瘤

第七章溶瘤病毒治疗市场：依最终用途分类 2022-2032

  • 市场概况
  • 成长/利润分析：2023 年与 2032 年
  • 2022-2032年数量和价格分析
  • 市场细分
    • 医院
    • 专科诊所
    • 癌症研究

第八章北美溶瘤病毒治疗市场2022-2032

  • 市场概况
  • 溶瘤病毒治疗市场：依病毒类型 2022-2032
  • 溶瘤病毒治疗市场：依应用分类 2022-2032
  • 溶瘤病毒疗法市场：依最终用途分类 2022-2032
  • 溶瘤病毒疗法市场：按地区划分 2022-2032
    • 北美
      • 美国
      • 加拿大
      • 其他北美

第九章英国及欧盟溶瘤病毒治疗市场2022-2032

  • 市场概况
  • 溶瘤病毒治疗市场：依病毒类型 2022-2032
  • 溶瘤病毒治疗市场：依应用分类 2022-2032
  • 溶瘤病毒疗法市场：依最终用途分类 2022-2032
  • 溶瘤病毒疗法市场：按地区划分 2022-2032
    • 英国和欧盟
      • 英国
      • 德国
      • 西班牙
      • 义大利
      • 法国
      • 欧洲其他地区

第10章亚太溶瘤病毒治疗市场2022-2032

  • 市场概况
  • 溶瘤病毒治疗市场：依病毒类型 2022-2032
  • 溶瘤病毒治疗市场：依应用分类 2022-2032
  • 溶瘤病毒疗法市场：依最终用途分类 2022-2032
  • 溶瘤病毒疗法市场：按地区划分 2022-2032
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 亚太其他地区

第十一章拉丁美洲溶瘤病毒治疗市场2022-2032

  • 市场概况
  • 溶瘤病毒治疗市场：依病毒类型 2022-2032
  • 溶瘤病毒治疗市场：依应用分类 2022-2032
  • 溶瘤病毒疗法市场：依最终用途分类 2022-2032
  • 溶瘤病毒疗法市场：按地区划分 2022-2032
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地区

第十二章中东和非洲溶瘤病毒治疗市场2022-2032

  • 市场概况
  • 溶瘤病毒治疗市场：依病毒类型 2022-2032
  • 溶瘤病毒治疗市场：依应用分类 2022-2032
  • 溶瘤病毒疗法市场：依最终用途分类 2022-2032
  • 溶瘤病毒疗法市场：按地区划分 2022-2032
    • 中东/非洲
      • GCC
      • 非洲
      • 其他中东/非洲地区

第十三章公司简介

  • Amgen
  • Genelux Corporation
  • Oncolytics Biotech
  • Sorrento Therapeutics
  • Transgene SA
  • Daiichi Sankyo Company
  • Shanghai Sunway Biotech Co Ltd
  • Takara Bio Inc.
  • PsiOxus Therapeutics
  • SillaJen Inc.
  • ViroCure
  • 其他主要公司
Product Code: 140069-01-24

The oncolytic virus therapy market is expected to grow at a CAGR of 27.5% during the forecast period of 2024 to 2032, driven by technological innovations, expanding applications, and a robust research landscape. Genetically engineered oncolytic viruses, oncolytic wild-type viruses, and targeted applications for solid tumors and melanoma define the therapeutic landscape. While challenges persist, the market's trajectory is optimistic, propelled by the collective efforts of healthcare professionals, researchers, and industry leaders. Regional dynamics underscore the importance of North America and the Asia-Pacific in shaping the market's future. Competitive trends highlight the strategic maneuvers of key players, reinforcing the market's competitive nature. As the forecast period unfolds, the oncolytic virus therapy market is expected to witness transformative developments, reaffirming its significance in the oncology domain.

Key Market Drivers of Oncolytic Virus Therapy Market

Advances in Genetically Engineered Oncolytic Viruses

The use of genetically engineered oncolytic viruses represents a groundbreaking frontier in cancer treatment. These viruses are tailored to selectively target cancer cells while sparing healthy tissues, minimizing side effects associated with traditional therapies. The development of engineered viruses with enhanced tumor specificity, increased replication capacity, and augmented therapeutic payloads has propelled the market forward. Evidence from clinical trials highlights the efficacy and safety of these viruses in various cancer types, fostering optimism among researchers and clinicians.

Oncolytic Wild-type Viruses Driving Therapeutic Innovation

Beyond engineered viruses, oncolytic wild-type viruses have emerged as key players in oncolytic virus therapy. These naturally occurring viruses exhibit inherent oncolytic properties, and ongoing research is uncovering their potential in cancer treatment. The adaptability of wild-type viruses to different tumor microenvironments and their ability to induce immunogenic cell death contribute to their therapeutic effectiveness. Evidence-based studies showcase the diverse applications of oncolytic wild-type viruses, providing a compelling narrative for their continued integration into cancer treatment protocols.

Application Focus on Solid Tumors and Melanoma

The increasing prevalence of solid tumors, coupled with the rising incidence of melanoma, has directed the spotlight toward these specific applications of oncolytic virus therapy. Clinical successes in treating solid tumors, including breast, lung, and colorectal cancers, underscore the therapy's potential across a spectrum of malignancies. Melanoma, notorious for its resistance to conventional treatments, has witnessed remarkable responses to oncolytic virus therapy, paving the way for tailored interventions. An in-depth analysis of market data from 2023 reveals the dominance of solid tumor applications, with melanoma exhibiting the highest CAGR during the forecast period.

Restraints in Oncolytic Virus Therapy Market

Challenges in Achieving Uniform Therapeutic Responses

Despite the promising advancements, challenges persist in achieving uniform therapeutic responses across diverse patient populations. Variability in individual immune responses, tumor heterogeneity, and the evolving nature of cancer present hurdles in standardizing oncolytic virus therapy outcomes. Evidence points to instances where certain patients exhibit limited responsiveness, emphasizing the need for personalized treatment strategies. Overcoming these challenges requires a deeper understanding of the complex interactions between viruses, tumors, and the immune system.

Market Segmentation Analysis

Segmentation by Virus Type Segmentation: Genetically Engineered Oncolytic Viruses vs. Oncolytic Wild-type Viruses (500 words)

In 2023, the oncolytic virus therapy market witnessed a significant revenue share from both genetically engineered and wild-type viruses. Genetically engineered viruses dominated the landscape, reflecting the ongoing trend of customization in cancer treatment. The forecast for 2024 to 2032 anticipates a continued dominance of genetically engineered viruses, driven by sustained research efforts and their proven efficacy. However, oncolytic wild-type viruses are expected to gain momentum, particularly in applications where their natural attributes align with therapeutic goals.

Segmentation by Application: Solid Tumor vs. Melanoma (500 words)

Solid tumors, encompassing a range of cancer types, emerged as the primary application of oncolytic virus therapy in 2023. The highest revenue and CAGR during the forecast period are attributed to solid tumor applications, emphasizing the broad utility of this therapy. Melanoma, characterized by its challenging treatment landscape, exhibited substantial growth, positioning itself as a frontrunner in terms of CAGR. The distinct characteristics of melanoma, including its immunogenic nature, make it an ideal candidate for oncolytic virus therapy.

Segmentation by End-use: Hospitals, Specialty Clinics, Cancer Research Institutes (500 words)

Hospitals, specialty clinics, and cancer research institutes constitute key end-users shaping the oncolytic virus therapy market. In 2023, hospitals led in both revenue generation and CAGR, reflecting their central role in providing comprehensive cancer care. Specialty clinics demonstrated a high CAGR, driven by their focused approach to cancer treatment. Cancer research institutes, at the forefront of innovation, contributed significantly to the therapy's development. The forecast underscores the sustained dominance of hospitals, with specialty clinics experiencing notable growth.

North America Remains the Global Leader

North America, with its robust healthcare infrastructure and substantial research investments, led in both the highest revenue percentage and CAGR in 2023. The region's commitment to technological innovation and collaborative research initiatives fosters a favorable environment for market expansion. Europe, while demonstrating a commendable CAGR, lagged slightly behind North America in revenue percentage. The Asia-Pacific region, marked by burgeoning healthcare markets and increasing awareness of advanced therapies, exhibited the highest CAGR, indicating untapped potential. The Middle East and Africa contributed modestly to the market, with diverse factors influencing regional dynamics.

Strategic Collaborations to Increase Market Share

Top players in the oncolytic virus therapy market, including pharmaceutical giants and innovative biotech firms, navigate a landscape shaped by strategic collaborations and technological advancements. In 2023, these players reported substantial revenues, with projections for the 2024 to 2032 period indicating further growth. Leading companies, such as Amgen, Genelux Corporation, Oncolytics Biotech, Sorrento Therapeutics, Transgene SA, Daiichi Sankyo Company, Shanghai Sunway Biotech Co Ltd, Takara Bio Inc., PsiOxus Therapeutics, SillaJen Inc. and ViroCure, employed diverse strategies to maintain their market positions. Collaborations with research institutions, expansion of product portfolios, and investments in clinical trials are key strategic initiatives driving these companies forward.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofOncolytic Virus Therapy market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Oncolytic Virus Therapy market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Virus Type

    • Genetically Engineered Oncolytic Viruses
  • Herpes Simplex Virus
  • Adenovirus
  • Vaccinia Virus
    • Oncolytic Wild-type Viruses
  • Reovirus
  • Newcastle Disease Virus
  • Vesicular Stomatitis Virus

Application

    • Solid Tumor
  • Breast Cancer
  • Prostate Cancer
  • Lung Cancer
  • Glioblastoma
    • Melanoma
  • Hematological Malignancies
  • Lymphoma
  • Leukemia
  • Myeloma

End Use

    • Hospitals
    • Specialty Clinics
    • Cancer Research Institutes

Region Segment (2021-2031; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Oncolytic Virus Therapy market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Oncolytic Virus Therapy market?
  • Which is the largest regional market for Oncolytic Virus Therapy market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Oncolytic Virus Therapy market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Oncolytic Virus Therapy market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Oncolytic Virus Therapy Market
  • 2.2. Global Oncolytic Virus Therapy Market, By Virus Type, 2023 (US$ Million)
  • 2.3. Global Oncolytic Virus Therapy Market, By Application, 2023 (US$ Million)
  • 2.4. Global Oncolytic Virus Therapy Market, By End Use, 2023 (US$ Million)
  • 2.5. Global Oncolytic Virus Therapy Market, By Geography, 2023 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2023

3. Oncolytic Virus Therapy Market: Competitive Analysis

  • 3.1. Market Positioning of Key Oncolytic Virus Therapy Market Vendors
  • 3.2. Strategies Adopted by Oncolytic Virus Therapy Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2023 Versus 2032

4. Oncolytic Virus Therapy Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Oncolytic Virus Therapy Market Value, 2022 - 2032, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. Oncolytic Virus Therapy Market: By Virus Type, 2022-2032, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 5.3. Volume and Pricing Analysis, 2022-2032
  • 5.4. Market Segmentation
    • 5.4.1. Genetically Engineered Oncolytic Viruses
      • 5.4.1.1. Herpes Simplex Virus
      • 5.4.1.2. Adenovirus
      • 5.4.1.3. Vaccinia Virus
    • 5.4.2. Oncolytic Wild-type Viruses
      • 5.4.2.1. Reovirus
      • 5.4.2.2. Newcastle Disease Virus
      • 5.4.2.3. Vesicular Stomatitis Virus

6. Oncolytic Virus Therapy Market: By Application, 2022-2032, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 6.3. Volume and Pricing Analysis, 2022-2032
  • 6.4. Market Segmentation
    • 6.4.1. Solid Tumor
      • 6.4.1.1. Breast Cancer
      • 6.4.1.2. Prostate Cancer
      • 6.4.1.3. Lung Cancer
      • 6.4.1.4. Glioblastoma
    • 6.4.2. Melanoma
      • 6.4.2.1. Hematological Malignancies
      • 6.4.2.2. Lymphoma
      • 6.4.2.3. Leukemia
      • 6.4.2.4. Myeloma

7. Oncolytic Virus Therapy Market: By End Use, 2022-2032, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2023 Versus 2032
  • 7.3. Volume and Pricing Analysis, 2022-2032
  • 7.4. Market Segmentation
    • 7.4.1. Hospitals
    • 7.4.2. Specialty Clinics
    • 7.4.3. Cancer Research Institutes

8. North America Oncolytic Virus Therapy Market, 2022-2032, USD (Million)

  • 8.1. Market Overview
  • 8.2. Oncolytic Virus Therapy Market: By Virus Type, 2022-2032, USD (Million)
  • 8.3. Oncolytic Virus Therapy Market: By Application, 2022-2032, USD (Million)
  • 8.4. Oncolytic Virus Therapy Market: By End Use, 2022-2032, USD (Million)
  • 8.5.Oncolytic Virus Therapy Market: By Region, 2022-2032, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. Oncolytic Virus Therapy Market: By Virus Type, 2022-2032, USD (Million)
        • 8.5.1.1.2. Oncolytic Virus Therapy Market: By Application, 2022-2032, USD (Million)
        • 8.5.1.1.3. Oncolytic Virus Therapy Market: By End Use, 2022-2032, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. Oncolytic Virus Therapy Market: By Virus Type, 2022-2032, USD (Million)
        • 8.5.1.2.2. Oncolytic Virus Therapy Market: By Application, 2022-2032, USD (Million)
        • 8.5.1.2.3. Oncolytic Virus Therapy Market: By End Use, 2022-2032, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. Oncolytic Virus Therapy Market: By Virus Type, 2022-2032, USD (Million)
        • 8.5.1.3.2. Oncolytic Virus Therapy Market: By Application, 2022-2032, USD (Million)
        • 8.5.1.3.3. Oncolytic Virus Therapy Market: By End Use, 2022-2032, USD (Million)

9. UK and European Union Oncolytic Virus Therapy Market, 2022-2032, USD (Million)

  • 9.1. Market Overview
  • 9.2. Oncolytic Virus Therapy Market: By Virus Type, 2022-2032, USD (Million)
  • 9.3. Oncolytic Virus Therapy Market: By Application, 2022-2032, USD (Million)
  • 9.4. Oncolytic Virus Therapy Market: By End Use, 2022-2032, USD (Million)
  • 9.5.Oncolytic Virus Therapy Market: By Region, 2022-2032, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. Oncolytic Virus Therapy Market: By Virus Type, 2022-2032, USD (Million)
        • 9.5.1.1.2. Oncolytic Virus Therapy Market: By Application, 2022-2032, USD (Million)
        • 9.5.1.1.3. Oncolytic Virus Therapy Market: By End Use, 2022-2032, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. Oncolytic Virus Therapy Market: By Virus Type, 2022-2032, USD (Million)
        • 9.5.1.2.2. Oncolytic Virus Therapy Market: By Application, 2022-2032, USD (Million)
        • 9.5.1.2.3. Oncolytic Virus Therapy Market: By End Use, 2022-2032, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. Oncolytic Virus Therapy Market: By Virus Type, 2022-2032, USD (Million)
        • 9.5.1.3.2. Oncolytic Virus Therapy Market: By Application, 2022-2032, USD (Million)
        • 9.5.1.3.3. Oncolytic Virus Therapy Market: By End Use, 2022-2032, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. Oncolytic Virus Therapy Market: By Virus Type, 2022-2032, USD (Million)
        • 9.5.1.4.2. Oncolytic Virus Therapy Market: By Application, 2022-2032, USD (Million)
        • 9.5.1.4.3. Oncolytic Virus Therapy Market: By End Use, 2022-2032, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. Oncolytic Virus Therapy Market: By Virus Type, 2022-2032, USD (Million)
        • 9.5.1.5.2. Oncolytic Virus Therapy Market: By Application, 2022-2032, USD (Million)
        • 9.5.1.5.3. Oncolytic Virus Therapy Market: By End Use, 2022-2032, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. Oncolytic Virus Therapy Market: By Virus Type, 2022-2032, USD (Million)
        • 9.5.1.6.2. Oncolytic Virus Therapy Market: By Application, 2022-2032, USD (Million)
        • 9.5.1.6.3. Oncolytic Virus Therapy Market: By End Use, 2022-2032, USD (Million)

10. Asia Pacific Oncolytic Virus Therapy Market, 2022-2032, USD (Million)

  • 10.1. Market Overview
  • 10.2. Oncolytic Virus Therapy Market: By Virus Type, 2022-2032, USD (Million)
  • 10.3. Oncolytic Virus Therapy Market: By Application, 2022-2032, USD (Million)
  • 10.4. Oncolytic Virus Therapy Market: By End Use, 2022-2032, USD (Million)
  • 10.5.Oncolytic Virus Therapy Market: By Region, 2022-2032, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. Oncolytic Virus Therapy Market: By Virus Type, 2022-2032, USD (Million)
        • 10.5.1.1.2. Oncolytic Virus Therapy Market: By Application, 2022-2032, USD (Million)
        • 10.5.1.1.3. Oncolytic Virus Therapy Market: By End Use, 2022-2032, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. Oncolytic Virus Therapy Market: By Virus Type, 2022-2032, USD (Million)
        • 10.5.1.2.2. Oncolytic Virus Therapy Market: By Application, 2022-2032, USD (Million)
        • 10.5.1.2.3. Oncolytic Virus Therapy Market: By End Use, 2022-2032, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. Oncolytic Virus Therapy Market: By Virus Type, 2022-2032, USD (Million)
        • 10.5.1.3.2. Oncolytic Virus Therapy Market: By Application, 2022-2032, USD (Million)
        • 10.5.1.3.3. Oncolytic Virus Therapy Market: By End Use, 2022-2032, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. Oncolytic Virus Therapy Market: By Virus Type, 2022-2032, USD (Million)
        • 10.5.1.4.2. Oncolytic Virus Therapy Market: By Application, 2022-2032, USD (Million)
        • 10.5.1.4.3. Oncolytic Virus Therapy Market: By End Use, 2022-2032, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. Oncolytic Virus Therapy Market: By Virus Type, 2022-2032, USD (Million)
        • 10.5.1.5.2. Oncolytic Virus Therapy Market: By Application, 2022-2032, USD (Million)
        • 10.5.1.5.3. Oncolytic Virus Therapy Market: By End Use, 2022-2032, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. Oncolytic Virus Therapy Market: By Virus Type, 2022-2032, USD (Million)
        • 10.5.1.6.2. Oncolytic Virus Therapy Market: By Application, 2022-2032, USD (Million)
        • 10.5.1.6.3. Oncolytic Virus Therapy Market: By End Use, 2022-2032, USD (Million)

11. Latin America Oncolytic Virus Therapy Market, 2022-2032, USD (Million)

  • 11.1. Market Overview
  • 11.2. Oncolytic Virus Therapy Market: By Virus Type, 2022-2032, USD (Million)
  • 11.3. Oncolytic Virus Therapy Market: By Application, 2022-2032, USD (Million)
  • 11.4. Oncolytic Virus Therapy Market: By End Use, 2022-2032, USD (Million)
  • 11.5.Oncolytic Virus Therapy Market: By Region, 2022-2032, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. Oncolytic Virus Therapy Market: By Virus Type, 2022-2032, USD (Million)
        • 11.5.1.1.2. Oncolytic Virus Therapy Market: By Application, 2022-2032, USD (Million)
        • 11.5.1.1.3. Oncolytic Virus Therapy Market: By End Use, 2022-2032, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. Oncolytic Virus Therapy Market: By Virus Type, 2022-2032, USD (Million)
        • 11.5.1.2.2. Oncolytic Virus Therapy Market: By Application, 2022-2032, USD (Million)
        • 11.5.1.2.3. Oncolytic Virus Therapy Market: By End Use, 2022-2032, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. Oncolytic Virus Therapy Market: By Virus Type, 2022-2032, USD (Million)
        • 11.5.1.3.2. Oncolytic Virus Therapy Market: By Application, 2022-2032, USD (Million)
        • 11.5.1.3.3. Oncolytic Virus Therapy Market: By End Use, 2022-2032, USD (Million)

12. Middle East and Africa Oncolytic Virus Therapy Market, 2022-2032, USD (Million)

  • 12.1. Market Overview
  • 12.2. Oncolytic Virus Therapy Market: By Virus Type, 2022-2032, USD (Million)
  • 12.3. Oncolytic Virus Therapy Market: By Application, 2022-2032, USD (Million)
  • 12.4. Oncolytic Virus Therapy Market: By End Use, 2022-2032, USD (Million)
  • 12.5.Oncolytic Virus Therapy Market: By Region, 2022-2032, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. Oncolytic Virus Therapy Market: By Virus Type, 2022-2032, USD (Million)
        • 12.5.1.1.2. Oncolytic Virus Therapy Market: By Application, 2022-2032, USD (Million)
        • 12.5.1.1.3. Oncolytic Virus Therapy Market: By End Use, 2022-2032, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. Oncolytic Virus Therapy Market: By Virus Type, 2022-2032, USD (Million)
        • 12.5.1.2.2. Oncolytic Virus Therapy Market: By Application, 2022-2032, USD (Million)
        • 12.5.1.2.3. Oncolytic Virus Therapy Market: By End Use, 2022-2032, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. Oncolytic Virus Therapy Market: By Virus Type, 2022-2032, USD (Million)
        • 12.5.1.3.2. Oncolytic Virus Therapy Market: By Application, 2022-2032, USD (Million)
        • 12.5.1.3.3. Oncolytic Virus Therapy Market: By End Use, 2022-2032, USD (Million)

13. Company Profile

  • 13.1. Amgen
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. Genelux Corporation
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. Oncolytics Biotech
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. Sorrento Therapeutics
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. Transgene SA
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. Daiichi Sankyo Company
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. Shanghai Sunway Biotech Co Ltd
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. Takara Bio Inc.
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. PsiOxus Therapeutics
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives
  • 13.10. SillaJen Inc.
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Portfolio
    • 13.10.4. Strategic Initiatives
  • 13.11. ViroCure
    • 13.11.1. Company Overview
    • 13.11.2. Financial Performance
    • 13.11.3. Product Portfolio
    • 13.11.4. Strategic Initiatives
  • 13.12. Other Notable Players
    • 13.12.1. Company Overview
    • 13.12.2. Financial Performance
    • 13.12.3. Product Portfolio
    • 13.12.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Oncolytic Virus Therapy Market By Virus Type, 2022-2032, USD (Million)
  • TABLE 2 Global Oncolytic Virus Therapy Market By Genetically Engineered Oncolytic Viruses, 2022-2032, USD (Million)

TABLE 3 Global Oncolytic Virus Therapy Market By Oncolytic Wild-type Viruses, 2022-2032, USD (Million)

TABLE 4 Global Oncolytic Virus Therapy Market By Application, 2022-2032, USD (Million)

  • TABLE 5 Global Oncolytic Virus Therapy Market By Solid Tumor, 2022-2032, USD (Million)

TABLE 6 Global Oncolytic Virus Therapy Market By Melanoma, 2022-2032, USD (Million)

TABLE 7 Global Oncolytic Virus Therapy Market By End Use, 2022-2032, USD (Million)

  • TABLE 8 North America Oncolytic Virus Therapy Market By Virus Type, 2022-2032, USD (Million)
  • TABLE 9 North America Oncolytic Virus Therapy Market By Genetically Engineered Oncolytic Viruses, 2022-2032, USD (Million)

TABLE 10 North America Oncolytic Virus Therapy Market By Oncolytic Wild-type Viruses, 2022-2032, USD (Million)

TABLE 11 North America Oncolytic Virus Therapy Market By Application, 2022-2032, USD (Million)

  • TABLE 12 North America Oncolytic Virus Therapy Market By Solid Tumor, 2022-2032, USD (Million)

TABLE 13 North America Oncolytic Virus Therapy Market By Melanoma, 2022-2032, USD (Million)

TABLE 14 North America Oncolytic Virus Therapy Market By End Use, 2022-2032, USD (Million)

  • TABLE 15 U.S. Oncolytic Virus Therapy Market By Virus Type, 2022-2032, USD (Million)
  • TABLE 16 U.S. Oncolytic Virus Therapy Market By Genetically Engineered Oncolytic Viruses, 2022-2032, USD (Million)

TABLE 17 U.S. Oncolytic Virus Therapy Market By Oncolytic Wild-type Viruses, 2022-2032, USD (Million)

TABLE 18 U.S. Oncolytic Virus Therapy Market By Application, 2022-2032, USD (Million)

  • TABLE 19 U.S. Oncolytic Virus Therapy Market By Solid Tumor, 2022-2032, USD (Million)

TABLE 20 U.S. Oncolytic Virus Therapy Market By Melanoma, 2022-2032, USD (Million)

TABLE 21 U.S. Oncolytic Virus Therapy Market By End Use, 2022-2032, USD (Million)

  • TABLE 22 Canada Oncolytic Virus Therapy Market By Virus Type, 2022-2032, USD (Million)
  • TABLE 23 Canada Oncolytic Virus Therapy Market By Genetically Engineered Oncolytic Viruses, 2022-2032, USD (Million)

TABLE 24 Canada Oncolytic Virus Therapy Market By Oncolytic Wild-type Viruses, 2022-2032, USD (Million)

TABLE 25 Canada Oncolytic Virus Therapy Market By Application, 2022-2032, USD (Million)

  • TABLE 26 Canada Oncolytic Virus Therapy Market By Solid Tumor, 2022-2032, USD (Million)

TABLE 27 Canada Oncolytic Virus Therapy Market By Melanoma, 2022-2032, USD (Million)

TABLE 28 Canada Oncolytic Virus Therapy Market By End Use, 2022-2032, USD (Million)

  • TABLE 29 Rest of North America Oncolytic Virus Therapy Market By Virus Type, 2022-2032, USD (Million)
  • TABLE 30 Rest of North America Oncolytic Virus Therapy Market By Genetically Engineered Oncolytic Viruses, 2022-2032, USD (Million)

TABLE 31 Rest of North America Oncolytic Virus Therapy Market By Oncolytic Wild-type Viruses, 2022-2032, USD (Million)

TABLE 32 Rest of North America Oncolytic Virus Therapy Market By Application, 2022-2032, USD (Million)

  • TABLE 33 Rest of North America Oncolytic Virus Therapy Market By Solid Tumor, 2022-2032, USD (Million)

TABLE 34 Rest of North America Oncolytic Virus Therapy Market By Melanoma, 2022-2032, USD (Million)

TABLE 35 Rest of North America Oncolytic Virus Therapy Market By End Use, 2022-2032, USD (Million)

  • TABLE 36 UK and European Union Oncolytic Virus Therapy Market By Virus Type, 2022-2032, USD (Million)
  • TABLE 37 UK and European Union Oncolytic Virus Therapy Market By Genetically Engineered Oncolytic Viruses, 2022-2032, USD (Million)

TABLE 38 UK and European Union Oncolytic Virus Therapy Market By Oncolytic Wild-type Viruses, 2022-2032, USD (Million)

TABLE 39 UK and European Union Oncolytic Virus Therapy Market By Application, 2022-2032, USD (Million)

  • TABLE 40 UK and European Union Oncolytic Virus Therapy Market By Solid Tumor, 2022-2032, USD (Million)

TABLE 41 UK and European Union Oncolytic Virus Therapy Market By Melanoma, 2022-2032, USD (Million)

TABLE 42 UK and European Union Oncolytic Virus Therapy Market By End Use, 2022-2032, USD (Million)

  • TABLE 43 UK Oncolytic Virus Therapy Market By Virus Type, 2022-2032, USD (Million)
  • TABLE 44 UK Oncolytic Virus Therapy Market By Genetically Engineered Oncolytic Viruses, 2022-2032, USD (Million)

TABLE 45 UK Oncolytic Virus Therapy Market By Oncolytic Wild-type Viruses, 2022-2032, USD (Million)

TABLE 46 UK Oncolytic Virus Therapy Market By Application, 2022-2032, USD (Million)

  • TABLE 47 UK Oncolytic Virus Therapy Market By Solid Tumor, 2022-2032, USD (Million)

TABLE 48 UK Oncolytic Virus Therapy Market By Melanoma, 2022-2032, USD (Million)

TABLE 49 UK Oncolytic Virus Therapy Market By End Use, 2022-2032, USD (Million)

  • TABLE 50 Germany Oncolytic Virus Therapy Market By Virus Type, 2022-2032, USD (Million)
  • TABLE 51 Germany Oncolytic Virus Therapy Market By Genetically Engineered Oncolytic Viruses, 2022-2032, USD (Million)

TABLE 52 Germany Oncolytic Virus Therapy Market By Oncolytic Wild-type Viruses, 2022-2032, USD (Million)

TABLE 53 Germany Oncolytic Virus Therapy Market By Application, 2022-2032, USD (Million)

  • TABLE 54 Germany Oncolytic Virus Therapy Market By Solid Tumor, 2022-2032, USD (Million)

TABLE 55 Germany Oncolytic Virus Therapy Market By Melanoma, 2022-2032, USD (Million)

TABLE 56 Germany Oncolytic Virus Therapy Market By End Use, 2022-2032, USD (Million)

  • TABLE 57 Spain Oncolytic Virus Therapy Market By Virus Type, 2022-2032, USD (Million)
  • TABLE 58 Spain Oncolytic Virus Therapy Market By Genetically Engineered Oncolytic Viruses, 2022-2032, USD (Million)

TABLE 59 Spain Oncolytic Virus Therapy Market By Oncolytic Wild-type Viruses, 2022-2032, USD (Million)

TABLE 60 Spain Oncolytic Virus Therapy Market By Application, 2022-2032, USD (Million)

  • TABLE 61 Spain Oncolytic Virus Therapy Market By Solid Tumor, 2022-2032, USD (Million)

TABLE 62 Spain Oncolytic Virus Therapy Market By Melanoma, 2022-2032, USD (Million)

TABLE 63 Spain Oncolytic Virus Therapy Market By End Use, 2022-2032, USD (Million)

  • TABLE 64 Italy Oncolytic Virus Therapy Market By Virus Type, 2022-2032, USD (Million)
  • TABLE 65 Italy Oncolytic Virus Therapy Market By Genetically Engineered Oncolytic Viruses, 2022-2032, USD (Million)

TABLE 66 Italy Oncolytic Virus Therapy Market By Oncolytic Wild-type Viruses, 2022-2032, USD (Million)

TABLE 67 Italy Oncolytic Virus Therapy Market By Application, 2022-2032, USD (Million)

  • TABLE 68 Italy Oncolytic Virus Therapy Market By Solid Tumor, 2022-2032, USD (Million)

TABLE 69 Italy Oncolytic Virus Therapy Market By Melanoma, 2022-2032, USD (Million)

TABLE 70 Italy Oncolytic Virus Therapy Market By End Use, 2022-2032, USD (Million)

  • TABLE 71 France Oncolytic Virus Therapy Market By Virus Type, 2022-2032, USD (Million)
  • TABLE 72 France Oncolytic Virus Therapy Market By Genetically Engineered Oncolytic Viruses, 2022-2032, USD (Million)

TABLE 73 France Oncolytic Virus Therapy Market By Oncolytic Wild-type Viruses, 2022-2032, USD (Million)

TABLE 74 France Oncolytic Virus Therapy Market By Application, 2022-2032, USD (Million)

  • TABLE 75 France Oncolytic Virus Therapy Market By Solid Tumor, 2022-2032, USD (Million)

TABLE 76 France Oncolytic Virus Therapy Market By Melanoma, 2022-2032, USD (Million)

TABLE 77 France Oncolytic Virus Therapy Market By End Use, 2022-2032, USD (Million)

  • TABLE 78 Rest of Europe Oncolytic Virus Therapy Market By Virus Type, 2022-2032, USD (Million)
  • TABLE 79 Rest of Europe Oncolytic Virus Therapy Market By Genetically Engineered Oncolytic Viruses, 2022-2032, USD (Million)

TABLE 80 Rest of Europe Oncolytic Virus Therapy Market By Oncolytic Wild-type Viruses, 2022-2032, USD (Million)

TABLE 81 Rest of Europe Oncolytic Virus Therapy Market By Application, 2022-2032, USD (Million)

  • TABLE 82 Rest of Europe Oncolytic Virus Therapy Market By Solid Tumor, 2022-2032, USD (Million)

TABLE 83 Rest of Europe Oncolytic Virus Therapy Market By Melanoma, 2022-2032, USD (Million)

TABLE 84 Rest of Europe Oncolytic Virus Therapy Market By End Use, 2022-2032, USD (Million)

  • TABLE 85 Asia Oncolytic Virus Therapy Market By Virus Type, 2022-2032, USD (Million)
  • TABLE 86 Asia Oncolytic Virus Therapy Market By Genetically Engineered Oncolytic Viruses, 2022-2032, USD (Million)

TABLE 87 Asia Oncolytic Virus Therapy Market By Oncolytic Wild-type Viruses, 2022-2032, USD (Million)

TABLE 88 Asia Oncolytic Virus Therapy Market By Application, 2022-2032, USD (Million)

  • TABLE 89 Asia Oncolytic Virus Therapy Market By Solid Tumor, 2022-2032, USD (Million)

TABLE 90 Asia Oncolytic Virus Therapy Market By Melanoma, 2022-2032, USD (Million)

TABLE 91 Asia Oncolytic Virus Therapy Market By End Use, 2022-2032, USD (Million)

  • TABLE 92 China Oncolytic Virus Therapy Market By Virus Type, 2022-2032, USD (Million)
  • TABLE 93 China Oncolytic Virus Therapy Market By Genetically Engineered Oncolytic Viruses, 2022-2032, USD (Million)

TABLE 94 China Oncolytic Virus Therapy Market By Oncolytic Wild-type Viruses, 2022-2032, USD (Million)

TABLE 95 China Oncolytic Virus Therapy Market By Application, 2022-2032, USD (Million)

  • TABLE 96 China Oncolytic Virus Therapy Market By Solid Tumor, 2022-2032, USD (Million)

TABLE 97 China Oncolytic Virus Therapy Market By Melanoma, 2022-2032, USD (Million)

TABLE 98 China Oncolytic Virus Therapy Market By End Use, 2022-2032, USD (Million)

  • TABLE 99 Japan Oncolytic Virus Therapy Market By Virus Type, 2022-2032, USD (Million)
  • TABLE 100 Japan Oncolytic Virus Therapy Market By Genetically Engineered Oncolytic Viruses, 2022-2032, USD (Million)

TABLE 101 Japan Oncolytic Virus Therapy Market By Oncolytic Wild-type Viruses, 2022-2032, USD (Million)

TABLE 102 Japan Oncolytic Virus Therapy Market By Application, 2022-2032, USD (Million)

  • TABLE 103 Japan Oncolytic Virus Therapy Market By Solid Tumor, 2022-2032, USD (Million)

TABLE 104 Japan Oncolytic Virus Therapy Market By Melanoma, 2022-2032, USD (Million)

TABLE 105 Japan Oncolytic Virus Therapy Market By End Use, 2022-2032, USD (Million)

  • TABLE 106 India Oncolytic Virus Therapy Market By Virus Type, 2022-2032, USD (Million)
  • TABLE 107 India Oncolytic Virus Therapy Market By Genetically Engineered Oncolytic Viruses, 2022-2032, USD (Million)

TABLE 108 India Oncolytic Virus Therapy Market By Oncolytic Wild-type Viruses, 2022-2032, USD (Million)

TABLE 109 India Oncolytic Virus Therapy Market By Application, 2022-2032, USD (Million)

  • TABLE 110 India Oncolytic Virus Therapy Market By Solid Tumor, 2022-2032, USD (Million)

TABLE 111 India Oncolytic Virus Therapy Market By Melanoma, 2022-2032, USD (Million)

TABLE 112 India Oncolytic Virus Therapy Market By End Use, 2022-2032, USD (Million)

  • TABLE 113 Australia Oncolytic Virus Therapy Market By Virus Type, 2022-2032, USD (Million)
  • TABLE 114 Australia Oncolytic Virus Therapy Market By Genetically Engineered Oncolytic Viruses, 2022-2032, USD (Million)

TABLE 115 Australia Oncolytic Virus Therapy Market By Oncolytic Wild-type Viruses, 2022-2032, USD (Million)

TABLE 116 Australia Oncolytic Virus Therapy Market By Application, 2022-2032, USD (Million)

  • TABLE 117 Australia Oncolytic Virus Therapy Market By Solid Tumor, 2022-2032, USD (Million)

TABLE 118 Australia Oncolytic Virus Therapy Market By Melanoma, 2022-2032, USD (Million)

TABLE 119 Australia Oncolytic Virus Therapy Market By End Use, 2022-2032, USD (Million)

  • TABLE 120 South Korea Oncolytic Virus Therapy Market By Virus Type, 2022-2032, USD (Million)
  • TABLE 121 South Korea Oncolytic Virus Therapy Market By Genetically Engineered Oncolytic Viruses, 2022-2032, USD (Million)

TABLE 122 South Korea Oncolytic Virus Therapy Market By Oncolytic Wild-type Viruses, 2022-2032, USD (Million)

TABLE 123 South Korea Oncolytic Virus Therapy Market By Application, 2022-2032, USD (Million)

  • TABLE 124 South Korea Oncolytic Virus Therapy Market By Solid Tumor, 2022-2032, USD (Million)

TABLE 125 South Korea Oncolytic Virus Therapy Market By Melanoma, 2022-2032, USD (Million)

TABLE 126 South Korea Oncolytic Virus Therapy Market By End Use, 2022-2032, USD (Million)

  • TABLE 127 Latin America Oncolytic Virus Therapy Market By Virus Type, 2022-2032, USD (Million)
  • TABLE 128 Latin America Oncolytic Virus Therapy Market By Genetically Engineered Oncolytic Viruses, 2022-2032, USD (Million)

TABLE 129 Latin America Oncolytic Virus Therapy Market By Oncolytic Wild-type Viruses, 2022-2032, USD (Million)

TABLE 130 Latin America Oncolytic Virus Therapy Market By Application, 2022-2032, USD (Million)

  • TABLE 131 Latin America Oncolytic Virus Therapy Market By Solid Tumor, 2022-2032, USD (Million)

TABLE 132 Latin America Oncolytic Virus Therapy Market By Melanoma, 2022-2032, USD (Million)

TABLE 133 Latin America Oncolytic Virus Therapy Market By End Use, 2022-2032, USD (Million)

  • TABLE 134 Brazil Oncolytic Virus Therapy Market By Virus Type, 2022-2032, USD (Million)
  • TABLE 135 Brazil Oncolytic Virus Therapy Market By Genetically Engineered Oncolytic Viruses, 2022-2032, USD (Million)

TABLE 136 Brazil Oncolytic Virus Therapy Market By Oncolytic Wild-type Viruses, 2022-2032, USD (Million)

TABLE 137 Brazil Oncolytic Virus Therapy Market By Application, 2022-2032, USD (Million)

  • TABLE 138 Brazil Oncolytic Virus Therapy Market By Solid Tumor, 2022-2032, USD (Million)

TABLE 139 Brazil Oncolytic Virus Therapy Market By Melanoma, 2022-2032, USD (Million)

TABLE 140 Brazil Oncolytic Virus Therapy Market By End Use, 2022-2032, USD (Million)

  • TABLE 141 Mexico Oncolytic Virus Therapy Market By Virus Type, 2022-2032, USD (Million)
  • TABLE 142 Mexico Oncolytic Virus Therapy Market By Genetically Engineered Oncolytic Viruses, 2022-2032, USD (Million)

TABLE 143 Mexico Oncolytic Virus Therapy Market By Oncolytic Wild-type Viruses, 2022-2032, USD (Million)

TABLE 144 Mexico Oncolytic Virus Therapy Market By Application, 2022-2032, USD (Million)

  • TABLE 145 Mexico Oncolytic Virus Therapy Market By Solid Tumor, 2022-2032, USD (Million)

TABLE 146 Mexico Oncolytic Virus Therapy Market By Melanoma, 2022-2032, USD (Million)

TABLE 147 Mexico Oncolytic Virus Therapy Market By End Use, 2022-2032, USD (Million)

  • TABLE 148 Rest of Latin America Oncolytic Virus Therapy Market By Virus Type, 2022-2032, USD (Million)
  • TABLE 149 Rest of Latin America Oncolytic Virus Therapy Market By Genetically Engineered Oncolytic Viruses, 2022-2032, USD (Million)

TABLE 150 Rest of Latin America Oncolytic Virus Therapy Market By Oncolytic Wild-type Viruses, 2022-2032, USD (Million)

TABLE 151 Rest of Latin America Oncolytic Virus Therapy Market By Application, 2022-2032, USD (Million)

  • TABLE 152 Rest of Latin America Oncolytic Virus Therapy Market By Solid Tumor, 2022-2032, USD (Million)

TABLE 153 Rest of Latin America Oncolytic Virus Therapy Market By Melanoma, 2022-2032, USD (Million)

TABLE 154 Rest of Latin America Oncolytic Virus Therapy Market By End Use, 2022-2032, USD (Million)

  • TABLE 155 Middle East and Africa Oncolytic Virus Therapy Market By Virus Type, 2022-2032, USD (Million)
  • TABLE 156 Middle East and Africa Oncolytic Virus Therapy Market By Genetically Engineered Oncolytic Viruses, 2022-2032, USD (Million)

TABLE 157 Middle East and Africa Oncolytic Virus Therapy Market By Oncolytic Wild-type Viruses, 2022-2032, USD (Million)

TABLE 158 Middle East and Africa Oncolytic Virus Therapy Market By Application, 2022-2032, USD (Million)

  • TABLE 159 Middle East and Africa Oncolytic Virus Therapy Market By Solid Tumor, 2022-2032, USD (Million)

TABLE 160 Middle East and Africa Oncolytic Virus Therapy Market By Melanoma, 2022-2032, USD (Million)

TABLE 161 Middle East and Africa Oncolytic Virus Therapy Market By End Use, 2022-2032, USD (Million)

  • TABLE 162 GCC Oncolytic Virus Therapy Market By Virus Type, 2022-2032, USD (Million)
  • TABLE 163 GCC Oncolytic Virus Therapy Market By Genetically Engineered Oncolytic Viruses, 2022-2032, USD (Million)

TABLE 164 GCC Oncolytic Virus Therapy Market By Oncolytic Wild-type Viruses, 2022-2032, USD (Million)

TABLE 165 GCC Oncolytic Virus Therapy Market By Application, 2022-2032, USD (Million)

  • TABLE 166 GCC Oncolytic Virus Therapy Market By Solid Tumor, 2022-2032, USD (Million)

TABLE 167 GCC Oncolytic Virus Therapy Market By Melanoma, 2022-2032, USD (Million)

TABLE 168 GCC Oncolytic Virus Therapy Market By End Use, 2022-2032, USD (Million)

  • TABLE 169 Africa Oncolytic Virus Therapy Market By Virus Type, 2022-2032, USD (Million)
  • TABLE 170 Africa Oncolytic Virus Therapy Market By Genetically Engineered Oncolytic Viruses, 2022-2032, USD (Million)

TABLE 171 Africa Oncolytic Virus Therapy Market By Oncolytic Wild-type Viruses, 2022-2032, USD (Million)

TABLE 172 Africa Oncolytic Virus Therapy Market By Application, 2022-2032, USD (Million)

  • TABLE 173 Africa Oncolytic Virus Therapy Market By Solid Tumor, 2022-2032, USD (Million)

TABLE 174 Africa Oncolytic Virus Therapy Market By Melanoma, 2022-2032, USD (Million)

TABLE 175 Africa Oncolytic Virus Therapy Market By End Use, 2022-2032, USD (Million)

  • TABLE 176 Rest of Middle East and Africa Oncolytic Virus Therapy Market By Virus Type, 2022-2032, USD (Million)
  • TABLE 177 Rest of Middle East and Africa Oncolytic Virus Therapy Market By Genetically Engineered Oncolytic Viruses, 2022-2032, USD (Million)

TABLE 178 Rest of Middle East and Africa Oncolytic Virus Therapy Market By Oncolytic Wild-type Viruses, 2022-2032, USD (Million)

TABLE 179 Rest of Middle East and Africa Oncolytic Virus Therapy Market By Application, 2022-2032, USD (Million)

  • TABLE 180 Rest of Middle East and Africa Oncolytic Virus Therapy Market By Solid Tumor, 2022-2032, USD (Million)

TABLE 181 Rest of Middle East and Africa Oncolytic Virus Therapy Market By Melanoma, 2022-2032, USD (Million)

TABLE 182 Rest of Middle East and Africa Oncolytic Virus Therapy Market By End Use, 2022-2032, USD (Million)

List of Figures

  • FIG. 1 Global Oncolytic Virus Therapy Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Oncolytic Virus Therapy Market: Quality Assurance
  • FIG. 5 Global Oncolytic Virus Therapy Market, By Virus Type, 2023
  • FIG. 6 Global Oncolytic Virus Therapy Market, By Application, 2023
  • FIG. 7 Global Oncolytic Virus Therapy Market, By End Use, 2023
  • FIG. 8 Global Oncolytic Virus Therapy Market, By Geography, 2023
  • FIG. 9 Market Geographical Opportunity Matrix - Global Oncolytic Virus Therapy Market, 2023

FIG. 10Market Positioning of Key Oncolytic Virus Therapy Market Players, 2023

FIG. 11Global Oncolytic Virus Therapy Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032

  • FIG. 12 Global Oncolytic Virus Therapy Market, By Virus Type, 2023 Vs 2032, %
  • FIG. 13 Global Oncolytic Virus Therapy Market, By Application, 2023 Vs 2032, %
  • FIG. 14 Global Oncolytic Virus Therapy Market, By End Use, 2023 Vs 2032, %
  • FIG. 15 U.S. Oncolytic Virus Therapy Market (US$ Million), 2022 - 2032
  • FIG. 16 Canada Oncolytic Virus Therapy Market (US$ Million), 2022 - 2032
  • FIG. 17 Rest of North America Oncolytic Virus Therapy Market (US$ Million), 2022 - 2032
  • FIG. 18 UK Oncolytic Virus Therapy Market (US$ Million), 2022 - 2032
  • FIG. 19 Germany Oncolytic Virus Therapy Market (US$ Million), 2022 - 2032
  • FIG. 20 Spain Oncolytic Virus Therapy Market (US$ Million), 2022 - 2032
  • FIG. 21 Italy Oncolytic Virus Therapy Market (US$ Million), 2022 - 2032
  • FIG. 22 France Oncolytic Virus Therapy Market (US$ Million), 2022 - 2032
  • FIG. 23 Rest of Europe Oncolytic Virus Therapy Market (US$ Million), 2022 - 2032
  • FIG. 24 China Oncolytic Virus Therapy Market (US$ Million), 2022 - 2032
  • FIG. 25 Japan Oncolytic Virus Therapy Market (US$ Million), 2022 - 2032
  • FIG. 26 India Oncolytic Virus Therapy Market (US$ Million), 2022 - 2032
  • FIG. 27 Australia Oncolytic Virus Therapy Market (US$ Million), 2022 - 2032
  • FIG. 28 South Korea Oncolytic Virus Therapy Market (US$ Million), 2022 - 2032
  • FIG. 29 Rest of Asia Oncolytic Virus Therapy Market (US$ Million), 2022 - 2032
  • FIG. 30 Brazil Oncolytic Virus Therapy Market (US$ Million), 2022 - 2032
  • FIG. 31 Mexico Oncolytic Virus Therapy Market (US$ Million), 2022 - 2032
  • FIG. 32 Rest of Latin America Oncolytic Virus Therapy Market (US$ Million), 2022 - 2032
  • FIG. 33 GCC Oncolytic Virus Therapy Market (US$ Million), 2022 - 2032
  • FIG. 34 Africa Oncolytic Virus Therapy Market (US$ Million), 2022 - 2032
  • FIG. 35 Rest of Middle East and Africa Oncolytic Virus Therapy Market (US$ Million), 2022 - 2032